DHEA supplementation positively affects spontaneous pregnancies in women with diminished ovarian function

References

• Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol 2011;9:23
   PubMed Web of Science ®Google Scholar
• Weghofer A, Kim A, Barad DH, Gleicher N. The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum Reprod 2012;27:3287–93
   PubMed Web of Science ®Google Scholar
• Hyman JH, Margalioth EJ, Rabinowitz R, et al. DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism. Eur J Obstet Gynecol Reprod Biol 2013;168:49--53
   PubMed Web of Science ®Google Scholar
• Vollenhoven B, Osianlis T, Catt J. Is there an ideal stimulation regimen for IVF for poor responders and does it change with age? J Assist Reprod Genet 2008;25:523–9
   PubMed Web of Science ®Google Scholar
• Ulug U, Ben-Shlomo I, Turan E, et al. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reprod Biomed Online 2003;6:439–43
   PubMedGoogle Scholar
• Mohamed KA, Davies WA, Allsopp J, Lashen H. Agonist ‘flare-up’ versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril 2005;83:331–5
   PubMed Web of Science ®Google Scholar
• Frattarelli JL, Hill MJ, McWilliams GD, et al. A luteal estradiol protocol for expected poor-responders improves embryo number and quality. Fertil Steril 2008;89:1118–22
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 2011;9:116
   PubMed Web of Science ®Google Scholar
• Casson PR, Lindsay MS, Pisarska MD, et al. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod 2002;15:2129–32
   Google Scholar
• Burger HG. Androgen production in women. Fertil Steril 2002;77:S3–5
   PubMed Web of Science ®Google Scholar
• Mamas L, Mamas E. Premature ovarian failure and dehydroepiandrosterone. Fertil Steril 2009;91:644–6
   PubMed Web of Science ®Google Scholar
• Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 2007;24:629–34
   PubMed Web of Science ®Google Scholar
• Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol 2011;9:67
   PubMed Web of Science ®Google Scholar
• Wiser A, Gonen O, Ghetler Y, et al. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod 2010;25:2496–500
   PubMed Web of Science ®Google Scholar
• Sönmezer M, Ozmen B, Cil AP, et al. Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders. Reprod Biomed Online 2009;19:508–13
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad DH. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reprod Biomed Online 2010;21:360–5
   PubMed Web of Science ®Google Scholar
• Weissman A, Horowitz E, Ravhon A, et al. Dehydroepiandrosterone supplementation increases baseline follicular phase progesterone levels. Gynecol Endocrinol 2011;27:1014–7
   PubMed Web of Science ®Google Scholar
• Artini PG, Simi G, Ruggiero M, et al. DHEA supplementation improves follicular microenviroment in poor responder patients. Gynecol Endocrinol 2012;28:669–73
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad DH. Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol 2010;8:140
   PubMed Web of Science ®Google Scholar
• Sunkara SK, Coomarasamy A, Arlt W, et al. Should androgen supplementation be used for poor ovarian response in IVF? Hum Reprod 2012;27:637–40
   PubMed Web of Science ®Google Scholar
• Hillier SG, Whitelaw PF, Smyth CD. Follicular estrogen synthesis: the ‘2-cell, two-gonadotrophin’ model revisited. Mol Cell Endocrinol 1994;100:51–4
   PubMed Web of Science ®Google Scholar
• Haning RV Jr, Hackett RJ, Flood CA, et al. Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J Clin Endocrinol Metab 1993;76:1301–7
   PubMed Web of Science ®Google Scholar
• Casson PR, Santoro N, Elkind-Hirsch K, et al. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil Steril 1998;70:107–10
   PubMed Web of Science ®Google Scholar
• Bahceci M, Ulug U, Turan E, Akman MA. Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist. Eur J Obstet Gynecol Reprod Biol 2007;130:93–8
   PubMedGoogle Scholar
• Howles CM, Loumaye E, Germond M, et al. Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in vitro fertilization? Hum Reprod 1999;14:1939–43
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Orisaka M, Cao M, et al. Growth differentiation factor-9 mediates follicle-stimulating hormone-thyroid hormone interaction in the regulation of rat preantral follicular development. Endocrinology 2009;150:5566–74
   PubMed Web of Science ®Google Scholar
• Hickey TE, Marrocco DL, Amato F, et al. Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells. Biol Reprod 2005;73:825–32
   PubMed Web of Science ®Google Scholar
• Gleicher N, Kim A, Weghofer A, et al. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). J Assist Reprod Genet 2013;30:49–62
   PubMedGoogle Scholar